FUTURE SUPPLY MODELS
new approach to supply chain management. For instance, gene therapies often involve the handling of highly sensitive biological materials that require specialised storage and transportation conditions. This necessitates close collaboration between pharmaceutical companies, contract research organisations (CROs), and logistics providers and clinical sites to ensure that the supply chain can support the unique demands of these therapies.
Collaborative and integrated supply networks The complexity of modern clinical trials necessitates a more collaborative approach to clinical supply management. The traditional silos between clinical operations, supply chain management, and manufacturing as well as the one between internal staff and vendors are breaking down, giving way to more integrated and collaborative networks. Strategic partnerships between pharmaceutical companies, CROs, and logistics providers are becoming more common, enabling a more seamless flow of information and coordination across the supply chain. These collaborations are essential for managing the increasing complexity of clinical trials, particularly in a global context. As trials become more decentralised and patient- centric, the ability to coordinate across multiple stakeholders becomes crucial. Collaborative supply networks allow for greater agility, enabling the supply chain to respond quickly to changing trial requirements and patient needs.
Sustainability and efficiency: priorities for the future Sustainability is no longer an option but a necessity in the future of clinical trial supply chains. The industry is increasingly recognising the need to adopt eco-friendly logistics, reduce waste, and optimise resource use. The 2024 Clinical Trial Supply Industry Trends Report highlights how sustainability is becoming an integral part of supply strategy, with advanced planning tools and AI-driven logistics solutions enabling more precise routing, inventory management, and a reduced environmental footprint. Efficiency and sustainability are closely
The future of clinical supply chains will be heavily influenced by the ability to harness more data, better data, and more connected data
linked. By leveraging digital technologies, supply chains can achieve greater operational efficiency while also minimising their environmental impact. For example, real-time monitoring of supply chain activities allows for better decision-making, reducing the likelihood of delays or disruptions that could result in waste. As sustainability continues to rise in importance, clinical supply chains must prioritise green practices to remain competitive and socially responsible.
Conclusion The future of clinical supply chain models is one of transformation and adaptation. As clinical trials become more global, decentralised, diverse and patient-centric, supply chains must evolve to meet the demands of modern research. By embracing emerging trends such as personalised supply models, AI-driven decision-making, and sustainable practices, clinical supply professionals can navigate the complexities of the future landscape. Collaborative and integrated supply networks, along with a focus on data quality and patient engagement, will be critical in ensuring that the clinical supply chain remains flexible, responsive, and capable of supporting the diverse needs of tomorrow’s clinical trials. The future of clinical supply chains will not
only reshape processes but will also require a workforce adept at navigating new technologies and global complexities, posing a critical challenge in bridging the skills gap and fostering a culture of continuous innovation. The need for visionary leadership to guide all those changes will be higher than ever.
Clinical Trial Supply Handbook | 39
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
